Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.

Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML.

Nat Genet. 2009 Aug;41(8):882-4. doi: 10.1038/ng.403. Epub 2009 Jun 28.

2.

New insights into the aetiology of colorectal cancer from genome-wide association studies.

Tenesa A, Dunlop MG.

Nat Rev Genet. 2009 Jun;10(6):353-8. doi: 10.1038/nrg2574. Review.

PMID:
19434079
4.

Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21.

Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ; Colorectal Cancer Study Group.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):616-21. doi: 10.1158/1055-9965.EPI-08-0690. Epub 2009 Jan 20.

5.

Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk.

Berndt SI, Potter JD, Hazra A, Yeager M, Thomas G, Makar KW, Welch R, Cross AJ, Huang WY, Schoen RE, Giovannucci E, Chan AT, Chanock SJ, Peters U, Hunter DJ, Hayes RB.

Hum Mol Genet. 2008 Sep 1;17(17):2665-72. doi: 10.1093/hmg/ddn166. Epub 2008 Jun 4.

6.

Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry.

Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S, Siegmund KD, Casey G, Thibodeau SN, Jenkins MA, Hopper JL, Byrnes GB, Baron JA, Goode EL, Tiirikainen M, Lindor N, Grove J, Newcomb P, Jass J, Young J, Potter JD, Haile RW, Duggan DJ, Le Marchand L; Colon CFR.

Cancer Res. 2007 Dec 1;67(23):11128-32.

7.

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A.

Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, Reynolds P, Hardy M, King E, Masters J, Hulme J, Maier LM, Smyth D, Bailey R, Cooper JD, Ribas G, Campbell RD, Clayton DG, Todd JA; Wellcome Trust Case Control Consortium.

Nature. 2007 Dec 6;450(7171):887-92. Epub 2007 Nov 14.

8.

Heterogeneity in meta-analyses of genome-wide association investigations.

Ioannidis JP, Patsopoulos NA, Evangelou E.

PLoS One. 2007 Sep 5;2(9):e841.

9.

Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24.

Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, Ferretti V, Laflamme P, Sundararajan S, Roumy S, Olivier JF, Robidoux F, Sladek R, Montpetit A, Campbell P, Bezieau S, O'Shea AM, Zogopoulos G, Cotterchio M, Newcomb P, McLaughlin J, Younghusband B, Green R, Green J, Porteous ME, Campbell H, Blanche H, Sahbatou M, Tubacher E, Bonaiti-PelliƩ C, Buecher B, Riboli E, Kury S, Chanock SJ, Potter J, Thomas G, Gallinger S, Hudson TJ, Dunlop MG.

Nat Genet. 2007 Aug;39(8):989-94. Epub 2007 Jul 8.

PMID:
17618283
10.

A haplotype map of the human genome.

International HapMap Consortium.

Nature. 2005 Oct 27;437(7063):1299-320.

11.

An update on the genetics of colorectal cancer.

Kemp Z, Thirlwell C, Sieber O, Silver A, Tomlinson I.

Hum Mol Genet. 2004 Oct 1;13 Spec No 2:R177-85. Review.

PMID:
15358723
12.

Haploview: analysis and visualization of LD and haplotype maps.

Barrett JC, Fry B, Maller J, Daly MJ.

Bioinformatics. 2005 Jan 15;21(2):263-5. Epub 2004 Aug 5.

PMID:
15297300
13.

The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.

Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S107-21. No abstract available.

PMID:
14575943
14.

Measuring inconsistency in meta-analyses.

Higgins JP, Thompson SG, Deeks JJ, Altman DG.

BMJ. 2003 Sep 6;327(7414):557-60. Review. No abstract available.

15.

Hereditary colorectal cancer.

Lynch HT, de la Chapelle A.

N Engl J Med. 2003 Mar 6;348(10):919-32. Review. No abstract available.

16.

Two-stage methods for the analysis of pooled data.

Stukel TA, Demidenko E, Dykes J, Karagas MR.

Stat Med. 2001 Jul 30;20(14):2115-30.

PMID:
11439425
17.

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, Hayes RB, Johnson CC, Mandel JS, Oberman A, O'Brien B, Oken MM, Rafla S, Reding D, Rutt W, Weissfeld JL, Yokochi L, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):273S-309S.

PMID:
11189684
18.

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K.

N Engl J Med. 2000 Jul 13;343(2):78-85.

19.

Bias in meta-analysis detected by a simple, graphical test.

Egger M, Davey Smith G, Schneider M, Minder C.

BMJ. 1997 Sep 13;315(7109):629-34.

20.

Energy balance and colon cancer--beyond physical activity.

Slattery ML, Potter J, Caan B, Edwards S, Coates A, Ma KN, Berry TD.

Cancer Res. 1997 Jan 1;57(1):75-80.

Supplemental Content

Support Center